Qizheng Tibetan Medicine has been included in the “Outstanding Cases of Social Responsibility of Chinese Private Enterprises (2023),” continuously demonstrating the responsibility and commitment of a national pharmaceutical enterprise.

Qizheng Tibetan Medicine (002287) has recently been successfully included in the “Outstanding Cases of Social Responsibility of Chinese Private Enterprises (2023)” released by the All-China Federation of Industry and Commerce, thanks to its outstanding sustainable practices and its firm commitment to social responsibility. This honor not only recognizes Qizheng Tibetan Medicine’s continuous exploration and innovation in the field of social responsibility over the years, but also acknowledges its contributions to high-quality economic and social development.

Qizheng Tibetan Medicine is a national pharmaceutical enterprise with a profound sense of mission. Upholding the noble mission of traditional Tibetan medicine—“to bring health to those in pain, longevity to the healthy, and freedom to the long-lived”—the company is committed to integrating the time-honored essence of Tibetan medicine with modern technology, thereby contributing to the cause of human health. Over the past nearly three decades, the company has not only achieved remarkable success in the exploration, research and development, production, and sales of classic traditional Tibetan medicines but has also demonstrated unique dedication and responsibility in the realm of social responsibility.

Promote socio-economic development

In 2022, Qizheng Tibetan Medicine achieved an operating revenue of 2.045 billion yuan. The company actively fulfilled its tax obligations, paying 277 million yuan in taxes that year. Its cumulative tax payments in Tibet have reached 2.788 billion yuan, making a significant contribution to local fiscal revenue and economic development.

Since its IPO in 2009, the company has been committed to giving back to shareholders and society, with total cash dividends distributed exceeding 2.3 billion yuan.

Outstanding employment absorption capacity

Since its launch in 2009, Qizheng Tibetan Medicine has seen a steady increase in its workforce, with the number of jobs it provides growing year after year. As of the end of 2023, the company had provided stable employment to more than 3,000 employees.

Meanwhile, the company places great importance on recruiting and nurturing college students from Tibetan areas. Over the three-year period from 2021 to 2023, the company has hired a total of 96 college students from Tibetan regions.

Focus on innovation with remarkable results.

From 2020 to 2022, over the past three years, Qizheng Tibetan Medicine’s total R&D expenditure reached 350 million yuan, and the number of R&D personnel has been increasing year by year, fully demonstrating the company’s commitment to and emphasis on innovative R&D.

As of the end of 2023, the company had accumulated a total of 148 patents, of which 88% were invention patents.

Green development continues to deepen.

In January 2022, the company was awarded the title of “National Green Demonstration Factory” by the Industrial Energy Conservation and Green Development Evaluation Center of the Ministry of Industry and Information Technology. In October of the same year, its subsidiary, Tibet Tibetan Medicine Group Co., Ltd., was designated as a “Lhasa City Pilot Enterprise for Green Development” by the People’s Government of Lhasa City. In December 2021, the company was included in the “2021 Green Manufacturing List” released by the Ministry of Industry and Information Technology.

Achieving this honor not only recognizes the company’s accomplishments in green development but also serves as an inspiration for the company to continue deepening its commitment to green development in the future.

Actively participate in public welfare and charity.

For many years, Qizheng Tibetan Medicine has extensively carried out public welfare and charitable activities in western regions such as Tibet, Qinghai, and Gansu, relying on the Qizheng Charitable Foundation. According to available information, from 2021 to 2023, Qizheng Tibetan Medicine’s annual investment in public welfare initiatives steadily increased, reaching RMB 4.8 million, RMB 6.85 million, and RMB 7.15 million respectively, and successfully completed 65 public welfare projects.

In 2023, Qizheng Public Welfare further expanded the reach of its charitable initiatives nationwide, and the light of Qizheng Public Welfare is now benefiting more people in need.
It is reported that “Outstanding Cases of Social Responsibility of Chinese Private Enterprises (2023)” was released by the All-China Federation of Industry and Commerce at the Second Session of the 13th Executive Committee Meeting and the Conference on Private Enterprises Boosting High-Quality Development in Yunnan. A total of 10 private entrepreneurs and 50 private enterprises were selected. The All-China Federation of Industry and Commerce, officially known as the China National Federation of Industry and Commerce, was established in 1953 with the aim of promoting the healthy development of the non-public sector economy and the healthy growth of individuals engaged in the non-public sector economy. The work of the Federation is an important component of the cause of the Party and the state.

Reporting media: Panorama Network

Report link: https://www.p5w.net/kuaixun/202403/t20240321_6000495.htm